Reports

At Medical Research Collaborative (MRC), the brunt of our time is spent researching, debating, vetting, writing, editing, and then ultimately disseminating reports/trade alerts to our Data Partners, while continuously monitoring/updating Data Partners on the target companies covered.

Customized Reports are compiled by request of interested parties, and become the co-ownership of such parties. They may copy, share, print, and disseminate these reports at will. However, certain of our reports will also find their way into this section and become available for public purchase/download.


Privacy

Client confidentiality is imperative to us; your identity and/or the identity of the firm you represent is kept strictly confidential. Please see our Privacy Notice for more information.

Refund Policy

As the content of our research contained within each report is considered proprietary information, and the viewing of a report containing our research equivalent to using that report, we do not issue refunds; therefore, all sales are final.

Terms of Use

Please review our Terms of Use before purchase.

For more information, please see our FAQ section. We may also be contacted directly. 


DISCLAIMER

The information contained in any and all research reports written, edited, and/or assembled by Medical Research Collaborative, LLC ("MRC") does not, and is not intended to, constitute legal or medical advice, and is for informational purposes only. In addition, we do not warrant or guarantee the success of any investment decision you make for yourself or on behalf of your firm in reliance upon the content of our research; trade ideas/alerts disseminated to subscribers are not recommendations to buy, sell, avoid, or sell short any security, and are for informational purposes only; we recommend securing the services of a registered investment advisor (which we are not) and performing your own independent investigations before acting on information from us.


Data Partner Service

Data Partner Service

MRC is proud to offer the following Data Partner Service, entitling Data Partners to full access to ..

$250.00

Customized Analysis

Customized Analysis

Medical Research Collaborative ("MRC") is proud to offer to the following Customized Analysis packag..

$2,250.00

Executive Summary of Legal Analysis on Amarin, et al. v. Hikma, et al.

Executive Summary of Legal Analysis on Amarin, et al. v. Hikma, et al.

Following is an executive summary of a legal analysis on Case No.: 2:16-cv-02525-MMD-NJK by Medica..

$0.00

AMRN: Market Headwinds and Inherent Weakness of the Vascepa IP

AMRN: Market Headwinds and Inherent Weakness of the Vascepa IP

AMRN: Market Headwinds and Inherent Weakness of the Vascepa IP   Summary Since having ..

$0.00

Showing 1 to 4 of 4 (1 Pages)